FTC Can Enforce Subpoena Against Watson CEO Bisaro
This article was originally published in The Pink Sheet Daily
Executive Summary
A D.C. magistrate judge grants FTC's request to enforce a subpoena against Bisaro and finds the agency did not share Watson's confidential information with Apotex.
You may also be interested in...
Watson CEO Bisaro Ordered To Comply With FTC Subpoena
Bisaro must testify about a settlement agreement to delay marketing generic Provigil, a federal judge says; decision follows a magistrate judge's recommendation.
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.